acuity - AYI
AYI
Close Chg Chg %
369.37 5.24 1.42%
Closed Market
374.60
+5.24 (1.42%)
Volume: 183.33K
Last Updated:
Dec 4, 2025, 3:59 PM EDT
Company Overview: acuity - AYI
AYI Key Data
| Open $368.68 | Day Range 366.03 - 379.16 |
| 52 Week Range 216.81 - 379.16 | Market Cap $11.31B |
| Shares Outstanding 30.61M | Public Float 30.49M |
| Beta 1.49 | Rev. Per Employee N/A |
| P/E Ratio 29.02 | EPS $12.85 |
| Yield 18.69% | Dividend $0.17 |
| EX-DIVIDEND DATE Oct 17, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 220.79K |
AYI Performance
| 1 Week | 0.84% | ||
| 1 Month | 2.50% | ||
| 3 Months | 9.22% | ||
| 1 Year | 13.79% | ||
| 5 Years | 200.54% |
AYI Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
11
Full Ratings ➔
About acuity - AYI
Acuity, Inc. is an industrial technology company, which engages in the provision of lighting and building management solutions and services. The firm operates through the following segments: Acuity Brands Lighting and Acuity Intelligent Spaces. The Acuity Brands Lighting segment focuses on the provision of sustainable and intelligent lighting solutions. The Acuity Intelligent Spaces segment includes manufacturing of smart and green spaces using disruptive technologies. Its brands include Aculux, American Electric Lighting, Cyclone, Dark to Light, eldoLED, Eureka, Fresco, and Gotham. The company was founded in 2001 and is headquartered in Atlanta, GA.
AYI At a Glance
Acuity, Inc.
1170 Peachtree Street NE
Atlanta, Georgia 30309-7676
| Phone | 1-404-853-1400 | Revenue | 4.35B | |
| Industry | Electrical Products | Net Income | 396.60M | |
| Sector | Producer Manufacturing | 2025 Sales Growth | 13.137% | |
| Fiscal Year-end | 08 / 2026 | Employees | 13,800 | |
| View SEC Filings |
AYI Valuation
| P/E Current | 29.02 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 26.046 |
| Price to Sales Ratio | 2.377 |
| Price to Book Ratio | 3.678 |
| Price to Cash Flow Ratio | 17.18 |
| Enterprise Value to EBITDA | 14.539 |
| Enterprise Value to Sales | 2.511 |
| Total Debt to Enterprise Value | 0.092 |
AYI Efficiency
| Revenue/Employee | 314,898.551 |
| Income Per Employee | 28,739.13 |
| Receivables Turnover | 7.317 |
| Total Asset Turnover | 1.014 |
AYI Liquidity
| Current Ratio | 1.953 |
| Quick Ratio | 1.33 |
| Cash Ratio | 0.50 |
AYI Profitability
| Gross Margin | 46.07 |
| Operating Margin | 14.207 |
| Pretax Margin | 11.51 |
| Net Margin | 9.126 |
| Return on Assets | 9.256 |
| Return on Equity | 15.542 |
| Return on Total Capital | 10.635 |
| Return on Invested Capital | 11.947 |
AYI Capital Structure
| Total Debt to Total Equity | 36.86 |
| Total Debt to Total Capital | 26.933 |
| Total Debt to Total Assets | 21.122 |
| Long-Term Debt to Equity | 36.005 |
| Long-Term Debt to Total Capital | 26.308 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Acuity - AYI
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 4.01B | 3.95B | 3.84B | 4.35B | |
Sales Growth
| +15.75% | -1.35% | -2.81% | +13.14% | |
Cost of Goods Sold (COGS) incl D&A
| 2.33B | 2.28B | 2.10B | 2.34B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 94.80M | 93.20M | 91.10M | 133.10M | |
Depreciation
| 53.80M | 51.10M | 51.40M | 56.60M | |
Amortization of Intangibles
| 41.00M | 42.10M | 39.70M | 76.50M | |
COGS Growth
| +15.13% | -2.24% | -7.98% | +11.65% | |
Gross Income
| 1.67B | 1.67B | 1.74B | 2.00B | |
Gross Income Growth
| +16.62% | -0.10% | +4.24% | +14.93% | |
Gross Profit Margin
| +41.75% | +42.28% | +45.35% | +46.07% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 1.16B | 1.17B | 1.19B | 1.38B | |
Research & Development
| 95.10M | 97.10M | 102.30M | 140.20M | |
Other SG&A
| 1.06B | 1.07B | 1.08B | 1.24B | |
SGA Growth
| +15.51% | +1.02% | +1.27% | +16.77% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 1.70M | 29.40M | 3.00M | 53.50M | |
EBIT after Unusual Expense
| 512.00M | 470.90M | 553.30M | 563.90M | |
Non Operating Income/Expense
| 8.90M | 3.70M | 20.60M | (21.20M) | |
Non-Operating Interest Income
| 2.10M | 9.00M | 29.80M | 20.50M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 27.00M | 27.90M | 25.30M | 42.50M | |
Interest Expense Growth
| +11.57% | +3.33% | -9.32% | +67.98% | |
Gross Interest Expense
| 27.00M | 27.90M | 25.30M | 42.50M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 493.90M | 446.70M | 548.60M | 500.20M | |
Pretax Income Growth
| +24.66% | -9.56% | +22.81% | -8.82% | |
Pretax Margin
| +12.33% | +11.30% | +14.28% | +11.51% | |
Income Tax
| 109.90M | 100.70M | 126.00M | 103.60M | |
Income Tax - Current - Domestic
| 83.90M | 121.50M | 140.20M | 127.00M | |
Income Tax - Current - Foreign
| 25.40M | 27.00M | 19.40M | 21.60M | |
Income Tax - Deferred - Domestic
| 600.00K | (47.80M) | (33.60M) | (45.00M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 384.00M | 346.00M | 422.60M | 396.60M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 384.00M | 346.00M | 422.60M | 396.60M | |
Net Income Growth
| +25.37% | -9.90% | +22.14% | -6.15% | |
Net Margin Growth
| +9.59% | +8.75% | +11.00% | +9.13% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 384.00M | 346.00M | 422.60M | 396.60M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 384.00M | 346.00M | 422.60M | 396.60M | |
EPS (Basic)
| 11.234 | 10.8785 | 13.683 | 12.852 | |
EPS (Basic) Growth
| +33.14% | -3.16% | +25.78% | -6.07% | |
Basic Shares Outstanding
| 34.18M | 31.81M | 30.89M | 30.86M | |
EPS (Diluted)
| 11.0838 | 10.7574 | 13.4393 | 12.5344 | |
EPS (Diluted) Growth
| +32.44% | -2.94% | +24.93% | -6.73% | |
Diluted Shares Outstanding
| 34.65M | 32.16M | 31.45M | 31.64M | |
EBITDA
| 608.50M | 593.50M | 647.40M | 750.50M | |
EBITDA Growth
| +14.60% | -2.47% | +9.08% | +15.93% | |
EBITDA Margin
| +15.19% | +15.02% | +16.85% | +17.27% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 392.00 | |
| Number of Ratings | 11 | Current Quarters Estimate | 4.302 | |
| FY Report Date | 02 / 2026 | Current Year's Estimate | 19.963 | |
| Last Quarter’s Earnings | 4.533 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 18.01 | Next Fiscal Year Estimate | 21.878 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 8 | 8 | 9 | 8 |
| Mean Estimate | 4.30 | 5.37 | 19.96 | 21.88 |
| High Estimates | 4.53 | 5.78 | 20.42 | 22.70 |
| Low Estimate | 4.06 | 5.19 | 19.24 | 20.78 |
| Coefficient of Variance | 4.07 | 3.50 | 1.74 | 2.87 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 5 | 5 | 5 |
| OVERWEIGHT | 1 | 1 | 2 |
| HOLD | 5 | 5 | 3 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Acuity - AYI
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Acuity - AYI
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | 10,545 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $370.34 per share | 3,905,235.30 |
| Oct 28, 2025 | Dianne S. Mills SVP & Chief HR Officer | 15,293 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $370.34 per share | 5,663,609.62 |
| Oct 28, 2025 | Dianne S. Mills SVP & Chief HR Officer | 18,179 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | 10,545 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $368.32 per share | 3,883,934.40 |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | 13,393 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $367.54 per share | 4,922,463.22 |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | 15,232 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $116.36 per share | 1,772,395.52 |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | 12,296 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $156.39 per share | 1,922,971.44 |
| Oct 28, 2025 | Karen J. Holcom SVP & Chief Financial Officer | 20,992 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | 14,257 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | 7,935 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 28, 2025 | Neil M. Ashe President & CEO; Director | 72,202 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $370.34 per share | 26,739,288.68 |
| Oct 28, 2025 | Neil M. Ashe President & CEO; Director | 94,613 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 28, 2025 | Neil M. Ashe President & CEO; Director | 51,139 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 28, 2025 | Karen J. Holcom SVP & Chief Financial Officer | 25,600 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $370.34 per share | 9,480,704.00 |
| Oct 28, 2025 | Karen J. Holcom SVP & Chief Financial Officer | 31,424 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Mark J. Sachleben Director | 2,262 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |